期刊文献+

替米沙坦对原发性高血压伴心室肥厚患者的影响 被引量:1

Effect of telmisartan on primary hypertension with ventricular hypertrophy patient
下载PDF
导出
摘要 目的探讨替米沙坦对原发性高血压伴心室肥厚患者的影响。方法 96例原发性高血压伴心室肥厚患者给予替米沙坦治疗6周。比较治疗前后血压变化情况,采用超声心动图对左室舒张末期内径(LVDd)、舒张末期室间隔厚度(IVST)、左室后壁厚度(PWT)进行检测,并计算左室质量指数(LVMI)。结果 96例患者治疗后收缩压、舒张压、IVST、PWT、LVMI均低于治疗前,差异均有统计学意义(P<0.05)。结论替米沙坦可用于原发性高血压伴心室肥厚患者的治疗。 Objective To discuss the effect of telmisartan on primary hypertension with ventricular hypertrophy patient.Methods 96 cases patients with primary hypertension associated with ventricular hypertrophy were treated with six weeks of telmisartan treatment.Compared blood pressure changes before and after treatment,with the use of echocardiography measured left ventricular end diastolic diameter(LVDd),end-diastolic interventricular septal thickness(IVST),left ventricular posterior wall thickness(PWT),and caculated left ventricular mass index(LVMI).Results Affter treatment,systolic blood pressure,diastolic blood pressure,IVST,PWT and LVMI of all patients were lower than those before treatment,and the difference were statistically significant(P〈0.05).Conclusion Telmisartan can be used to treat primary hypertension with ventricular hypertrophy patient.
作者 权亚梅 魏强
出处 《临床合理用药杂志》 2012年第16期3-4,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 替米沙坦 高血压 原发性 心室肥厚 Telmisartan Hypertension,primary Ventricular hypertrophy
  • 相关文献

参考文献5

二级参考文献32

  • 1Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult : a report of the american College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol, 2005,46 : el -e82.
  • 2Persoon-Rothert M, van der WK, van der LA. Mechanical overload-induced apoptosis: a study in cultured neonatal ventricular myocytes and fibroblasts. Mol Cell Biochem, 2002, 241:115-124.
  • 3Okada K, Minamino T, Tsukamoto Y, et al. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation, 2004,110 : 7051 712.
  • 4Diep QN, El Mabrouk M, Yue P, et al. Effect of AT( 1 ) receptor blockade on cardiac apoptosis in angiotensin Ⅱ-induced hypertension. Am J Physiol Heart Circ Physiol , 2002,282: H1635-H1641.
  • 5Fortuno MA, Gonzalez A, Ravassa S, et al. Clinical implications of apoptosis in hypertensive heart disease. Am J Physiol Heart Circ Physiol, 2003,284 : H1495-H1506.
  • 6Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction : pathophysiology and Therapy. Circulation, 2000,101 : 2981-2988.
  • 7Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev, 1999,13 : 1211-1233.
  • 8Oyadomari S, Mori M. Roles of CHOP//GADD153 in endoplasmic reticulum stress. Cell Death Differ, 2003,11 : 381- 389.
  • 9Hamada H, Suzuki M, Yuasa S, et al. Dilated cardiomyopathy caused by aberrant endoplasmic reticulum quality control in mutant KDEL receptor transgenic mice. Mol Cell Biol, 2004,24 : 8007- 8017.
  • 10Sharov VG, Sabbah HN, Shimoyama H, et al. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol, 1996,148 : 141-149.

共引文献31

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部